NIA Small Business Funding Opportunities
NIA participates in a broad range of funding opportunities, research and development (R&D) programs, and technical assistance that address innovations in healthy aging as well as Alzheimer’ disease and related dementias (AD/ADRD).
This page lists opportunities that are currently open for new submissions, as well as details about a select set of expired announcements. Contact the NIA Small Business Programs team to determine whether your project is a good fit for NIA.
Already an awardee? Explore our resources and innovator support programs.
NIA Entrepreneurial Development Funding
NIA’s Research and Entrepreneurial Development Immersion (REDI) funding opportunities support entrepreneurial development for early-career scientists working in the fields of aging and aging-related diseases, including AD. Learn more about REDI.
|
Title |
Links |
Key Details |
|---|---|---|
|
REDI: Entrepreneurial Small Business Transition Award |
Clinical trial required |
Letters of Intent due: January 17, 2023 Applications due: February 17, 2023 Budget limits: $400,000 for Phase I; $2 million for Fast Track NIA contact: Saroj Regmi |
NIA SBIR and STTR Omnibus Funding
This funding opportunity supports investigator-initiated small business research projects focused on a broad range of aging-related innovations that align with NIA’s research priorities. Projects focused on AD may have the best fit in AD-specific opportunities.
|
Title |
Links |
Key Details |
|---|---|---|
|
2022 NIH SBIR/STTR Omnibus Solicitation |
Clinical trial required |
Standard due dates: January 5, April 5, September 5 Budget limits: Phase I $300,000; Phase II $2 million NIA contact: Michael-David A.R.R. Kerns |
|
2022 NIH SBIR/STTR Omnibus Solicitation |
Clinical trial not allowed |
Standard due dates: January 5, April 5, September 5 Budget limits: Phase I $300,000; Phase II $2 million NIA contact: Michael-David A.R.R. Kerns |
More Omnibus Funding Information
- 2022 NIA SBIR/STTR Program Descriptions and Research Topics (PDF, 1.8M)
- 2022 NIH SBIR/STTR Omnibus SBA-Approved Waiver Research Topics (PDF, 400K)
NIH SBIR Contracts Funding
NIA participates in the annual NIH SBIR contracts solicitation, which aims to spur development of specific R&D innovations that address key priorities. In 2023, NIA has requested proposals for three topics. Learn more about SBIR contracts and 2023 NIA topics.
|
Title |
Links |
Key Details |
|---|---|---|
|
2023 NIH SBIR Contracts Solicitation |
Due Date: November 4, 2022, 5 PM ET Budget limits: See topic information NIA contact: Karen Mahon |
NIA SBIR and STTR Opportunities Targeting AD/ADRD
This type of funding announcement supports investigator-initiated small business research projects focused on developing a variety of AD/ADRD-related innovations.
|
Title |
Links |
Key Details |
|---|---|---|
|
Advancing Research on AD and ADRD |
Clinical trial optional |
Standard due dates: January 5, April 5, September 5 Budget limits: Phase I $500,000; Phase II $2.5 million NIA contact: Michael-David A.R.R. Kerns |
NIH Commercialization Readiness Pilot (CRP) Program
This program supports Phase II and Phase IIB awardees seeking additional capital to advance toward commercialization. CRP offers technical assistance to help develop regulatory strategy and submissions to the U.S Food and Drug Administration and other agencies. CRP also supports manufacturing, replication of key studies, compliance activities, and other commercialization readiness research.
|
Title |
Links |
Key Details |
|---|---|---|
|
CRP Technical Assistance |
Clinical trial not allowed |
Standard due dates: January 5, April 5, September 5 Budget limit: $300,000 NIA contact: Saroj Regmi |
|
CRP Technical Assistance and Late Stage Development |
Clinical trial not allowed |
Standard due dates: January 5, April 5, September 5 Budget limit: $1.75 million/year for 2 years ($3.3 million total) NIA contact: Saroj Regmi |
|
CRP Technical Assistance and Late Stage Development |
Clinical trial required |
Standard due dates: January 5, April 5, September 5 Budget limit: $1.75 million/year for 2 years ($3.3 million total) NIA contact: Saroj Regmi |
NIH Special Initiatives
NIA participates in the following mission-related special initiatives and funding opportunities led by other NIH Institutes, Offices, and Centers.
|
Title |
Links |
Key Details |
|---|---|---|
| SBIR Technology Transfer |
Clinical trial not allowed |
Standard due dates: January 5, April 5, September 5 Budget limits: Phase I $300,000; Phase II $2 million NIA contact: Michael-David A.R.R. Kerns |
|
Non-Viral Technologies for In Vivo Delivery of Genome Editors |
Clinical trial not allowed |
Standard due dates: January 5, April 5, September 5 Budget limits: Phase I $300,000; Phase II $2 million NIA contact: Michael-David A.R.R. Kerns |
|
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management |
Clinical trial required |
Standard due dates: January 5, April 5, September 5 Budget limits: Phase I $300,000; Phase II $2 million NIA contact: Michael-David A.R.R. Kerns |
|
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management |
Clinical trial not allowed |
Standard due dates: January 5, April 5, September 5 Budget limits: Phase I $300,000; Phase II $2 million NIA contact: Michael-David A.R.R. Kerns |
NIH Administrative Supplements and Notices
Funded awardees can access additional NIA support via administrative supplements.
|
Title |
Links |
Key Details |
|---|---|---|
|
Promoting Diversity in SBIR |
Clinical trial not allowed |
Due dates: Rolling submissions accepted until September 10, 2024 Budget limit: $250,000 in direct costs NIA contact: Armineh Ghazarian |
|
Administrative Supplements to Existing NIH Grants and Cooperative Agreements to Address Unexpected Costs |
Clinical trial optional |
Due dates: Rolling submissions accepted until October 8, 2023 Budget limit: $250,000 in direct costs NIA contact: Saroj Regmi |
Select Expired NIA Funding Opportunities
Research and Entrepreneurial Development Immersion (REDI)
REDI funding opportunities support entrepreneurial development for early-career scientists working in the fields of aging and aging-related diseases, including AD, by providing bio-entrepreneurship training that builds additional nonacademic skills for success. Learn more about REDI and view the pre-application webinar recording.
SBIR Contracts Solicitation
NIA began participating in the annual NIH SBIR contracts solicitation in fiscal year 2022. These funding opportunities aim to spur development of specific innovations that address key Institute priorities. Learn more about past NIA SBIR contract topics.
NIA Healthy Aging Start-Up Challenge and Bootcamp to Foster Diversity and Accelerate Innovation
NIA launched this Challenge in spring 2022 to stimulate innovation and foster diversity in aging research and development by providing cash prizes and non-cash prizes that will help participants overcome barriers to participating in life sciences entrepreneurship, particularly for researchers with a demonstrated need who have innovative ideas for science-driven technologies and products. Learn more about the Challenge.
Ready to apply?
- Confirm your eligibility.
- Review tips for applicants.
- Contact the NIA Small Business Programs to discuss fit.
Return to the NIA Small Business Main Page.